fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Mutual Funds » Nippon India PHARMA Fund

Nippon India PHARMA Fund - G

NAV  ₹260.988 ↑ 0.88  (0.34 %) as on 24 Jun 22

Scheme Objective

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Nippon India Pharma Fund is a Equity - Sectoral fund launched on 5 Jun 04. It is a fund with High risk and has given a CAGR return of 19.8% since its launch.  Ranked 35 in Sectoral category.  Return for 2021 was 23.9% , 2020 was 66.4% and 2019 was 1.7% .

Below is the key information for Nippon India Pharma Fund

NAV as on 24 Jun 22₹260.988 ↑ 0.88  (0.34 %)
Net Assets (AUM) as on 31 May 2022 ₹4,516 Cr.
Launch Date5 Jun 2004
CategoryEquity - Sectoral
Rating
TypeOpen Ended Fund
RiskHigh
AMCNippon Life Asset Management Ltd.
Alpha Ratio-1.22
Expense Ratio0.96 %
Sharpe Ratio-0.797
Information Ratio0.68
BenchmarkNot Available
Min Investment ₹5,000
Min SIP Investment ₹100
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Returns

Annual Compounded Returns

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 24 Jun 22

DurationReturns
1 Month -1.7%
3 Month -10.3%
6 Month -12.2%
1 Year -12.4%
3 Year 23.3%
5 Year 15.5%
10 Year
15 Year
Since launch 19.8%

Historical Annual Returns

Historical performance (Yearly) on absolute basis

YearReturns
2021 23.9%
2020 66.4%
2019 1.7%
2018 3.6%
2017 7.6%
2016 -10.6%
2015 19.4%
2014 49.5%
2013 20.9%

Growth of 10k Over Years

DateValue
31 May 17₹10,000
31 May 18₹11,117
31 May 19₹11,853
31 May 20₹15,327
31 May 21₹24,063
31 May 22₹22,001
Nippon India PHARMA Fund Growth 10k Chart

Asset Allocation

Asset ClassValue
Cash1.33%
Equity98.67%
Nippon India PHARMA Fund Asset Allocation

Sector Allocation

SectorValue
Health Care98.17%
Nippon India PHARMA Fund Equity Allocation

Top Securities Holdings / Portfolio

Holdings/Securities

NameGlobal IndustryHoldingValueQuantity
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 09 | SUNPHARMA
Drug Manufacturers - Specialty & Generic14%₹678 Cr7,300,976
Cipla Ltd (Healthcare)
Equity, Since 31 May 08 | CIPLA
Drug Manufacturers - General8%₹412 Cr4,200,000
Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB
Drug Manufacturers - Specialty & Generic8%₹383 Cr850,000
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 30 Jun 11 | DRREDDY
Drug Manufacturers - Specialty & Generic7%₹355 Cr858,077
Lupin Ltd (Healthcare)
Equity, Since 31 Aug 08 | LUPIN
Drug Manufacturers - Specialty & Generic7%₹320 Cr4,300,025
Torrent Pharmaceuticals Ltd (Healthcare)
Equity, Since 30 Sep 20 | TORNTPHARM
Drug Manufacturers - Specialty & Generic6%₹298 Cr1,057,600
Narayana Hrudayalaya Ltd (Healthcare)
Equity, Since 30 Jun 17 | NH
Medical Care Facilities6%₹290 Cr4,142,057
↓ -220,567
Abbott India Ltd (Healthcare)
Equity, Since 31 May 11 | ABBOTINDIA
Drug Manufacturers - General5%₹243 Cr142,537
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Dec 15 | AUROPHARMA
Drug Manufacturers - Specialty & Generic5%₹220 Cr3,500,000
Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Aug 18 | FORTIS
Medical Care Facilities4%₹183 Cr6,840,000
1 - 10 of 30
Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Fund Managers

NameSinceTenure
Sailesh Raj Bhan1 Apr 0517.18 Yr.
Kinjal Desai25 May 184.02 Yr.

Custodians

CompanyAddress
Deutsche Bank AGDeutsche Bank AG,Kodak House, 22, D.N. Road,

Registrar & Transfer Agent

KFin Technologies Limited
AddressKFin Technologies Pvt. Ltd,,1D/D Extension 2, Valmiki Chowk,,Gandhi Nagar,
FAX91-40-23311968
Emailmailmanager@karvy.com

Administrator Companies

CompanyAddress
Nippon India Mutual Fund9th Floor, Crescenzo, C-38 & 39,,G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400051

Auditors

CompanyAddress
Haribhakti & Co. Chartered Accountants42, Free Press House,4th Floor,,215, Nariman Point,

All Plan & Options

Fund and PlanNAV6 Month1 Year3 Year5 Year
Nippon India Pharma Fund
Normal Dividend, Payout
₹72.4715
↑ 0.24
-8.34 %-8.54 %27.84 %17.78 %
Nippon India Pharma Fund
Normal Dividend, Reinvestment
₹72.4715
↑ 0.24
-8.34 %-8.54 %27.84 %17.78 %
Nippon India Pharma Fund
Growth
₹260.988
↑ 0.88
-12.17 %-12.37 %23.29 %15.49 %
Data as on 24 Jun 22

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data.